FFRangio System vs Affiniti Series Diagnostic Ultrasound Systems

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

Affiniti Series Diagnostic Ultrasound Systems

by Philips Ultrasound

AI Verdict

The FFRangio System is an AI-powered tool specifically for interventional cardiology, providing functional assessment of coronary artery disease to guide PCI decisions. In contrast, the Affiniti Series Diagnostic Ultrasound Systems are broad diagnostic imaging platforms utilizing ultrasound technology, including AI, for visualization across multiple specialties like cardiology, OB/GYN, and radiology. While both incorporate AI in cardiology, their core functionalities diverge significantly, with one focused on interventional guidance and the other on general diagnostic imaging.

Choose FFRangio System if…

Choose the CathWorks FFRangio System if your cardiology practice requires precise, real-time physiological guidance during percutaneous coronary intervention (PCI) without the need for invasive pressure wires or vasoactive drugs. This system is ideal for optimizing and confirming PCI decisions by providing wire-free 3D FFR values and advanced insights directly within the cath lab, streamlining procedures and enhancing patient safety.

View FFRangio System →

Choose Affiniti Series Diagnostic Ultrasound Systems if…

Choose Philips Affiniti Series Diagnostic Ultrasound Systems if your facility needs a versatile, high-quality imaging solution for a broad range of clinical applications, including cardiology, OB/GYN, and general radiology. These systems are well-suited for practices seeking diagnostic confidence and reproducibility through advanced features like PureWave technology and Anatomical Intelligence, offering a robust "mid-tier" option for everyday ultrasound workflows.

View Affiniti Series Diagnostic Ultrasound Systems →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	Affiniti Series Diagnostic Ultrasound Systems
Pricing	Contact vendor for pricing information.	Varies by model and condition (new/refurbished). generally considered a 'mid tier' or 'budget' shared service ultrasound with rich image quality at an affordable price point compared to premium models.
Deployment	SaaS, on-prem, hybrid	On-premise (console hardware system)
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FFRangio System

Tool A (FFRangio System) emphasizes an 'intuitive user interface' and 'seamless integration with cath lab boom and PACS', directly simplifying a complex, invasive procedure by making it wire-free and drug-free. While Tool B (Affiniti Series) also highlights 'efficient workflows' and 'simplified user experience' for everyday ultrasound, Tool A's innovation in reducing procedural complexity offers a more significant leap in usability for its specific application.

Clinical Value

FFRangio System

Tool A (FFRangio System) provides a targeted and transformative clinical value by offering wire-free and drug-free 3D FFR guidance, delivering accurate multi-vessel FFR results to optimize PCI decisions. This directly addresses a critical decision point in cardiology with high diagnostic accuracy and comparable clinical outcomes to invasive FFR. Tool B (Affiniti Series) offers broad clinical value through advanced imaging across diverse specialties, but its impact is more incremental compared to Tool A's paradigm shift in FFR assessment.

Pricing & Value

Affiniti Series Diagnostic Ultrasound Systems

Tool B (Affiniti Series) offers transparent pricing information, positioning itself as a 'mid-tier' or 'budget' option with specific refurbished prices available. This allows potential buyers to assess its value proposition directly. Tool A (FFRangio System) only states 'contact for pricing', making it impossible to evaluate its cost-effectiveness without direct engagement.

Enterprise Readiness

Affiniti Series Diagnostic Ultrasound Systems

Both tools are on-premise hardware systems with FDA clearance. However, Tool B (Affiniti Series) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption and data security. Tool A (FFRangio System) is ISO 27001 certified for information security but its HIPAA compliance is 'unknown' and BAA is only 'likely' but not explicitly stated.

Innovation

FFRangio System

Tool A (FFRangio System) represents a significant innovation by providing wire-free and drug-free 3D FFR guidance, transforming how coronary artery disease is diagnosed and treated by eliminating invasive pressure wires and pharmacologic hyperemia. This is a disruptive approach to a critical diagnostic procedure. Tool B (Affiniti Series) offers advancements in ultrasound imaging technology like PureWave and Anatomical Intelligence, which are valuable but more iterative improvements within existing ultrasound modalities.

Support & Docs

Affiniti Series Diagnostic Ultrasound Systems

While specific details on support and documentation are limited for both in the provided facts, Philips (Tool B) is a large, established medical device company with extensive global support infrastructure and readily available documentation for its Affiniti series. CathWorks (Tool A), while offering an 'Instructions For Use' document, is a more specialized company, and its public-facing support resources appear less comprehensive compared to Philips' broad offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	Affiniti Series Diagnostic Ultrasound Systems
Name	FFRangio System	Affiniti Series Diagnostic Ultrasound Systems
Company	CathWorks	Philips Ultrasound
Description	The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.	The Philips Affiniti Series Diagnostic Ultrasound Systems offer advanced imaging for diverse clinical needs, featuring PureWave technology, Anatomical Intelligence, and efficient workflows for confident diagnosis.
Tagline	A New Era in Coronary Physiology	Designed for everyday ultrasound workflow, delivering diagnostic confidence and reproducibility.
Specialties	Cardiology	Cardiology, Obstetrics & Gynecology, Radiology
Key Features (partial)	Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia	PureWave crystal technology, Tissue Specific Presets (TSPs), Anatomical Intelligence Ultrasound (AIUS)

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and Affiniti Series Diagnostic Ultrasound Systems.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and benefits of each tool for cardiology patients?

The CathWorks FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease, offering real-time FFRangio values and insights like lesion impact. The Philips Affiniti Series Diagnostic Ultrasound Systems offer advanced diagnostic imaging for diverse clinical needs, including adult and pediatric echocardiography, stress echo, and general cardiac imaging, featuring technologies like PureWave and Anatomical Intelligence.

How do the technologies used by each system differ in assessing coronary artery disease?

The FFRangio System utilizes artificial intelligence and advanced computational science to obtain physiologic information and FFR values from routine angiograms, eliminating the need for invasive pressure wires or hyperemic agents. In contrast, the Affiniti Series Ultrasound Systems employ advanced ultrasound technologies such as PureWave crystal technology, Tissue Specific Presets, and Anatomical Intelligence Ultrasound (AIUS) for diagnostic imaging, including AI-enabled automated segmental wall motion scoring for cardiac assessment.

What are the key differences in how each tool contributes to diagnostic confidence and treatment planning?

The FFRangio System provides real-time FFRangio values at every point on the coronary tree, a simulated pullback curve to differentiate functional CAD patterns, and a lesion impact feature to assess residual ischemia, aiding in optimizing and confirming PCI decisions. The Affiniti Series Ultrasound Systems offer rich image quality, efficient workflows, and Anatomical Intelligence to deliver diagnostic confidence and reproducibility across diverse clinical needs, including advanced features like elastography and automated measurements.

What are the compliance and data security assurances for each system, especially concerning Protected Health Information (PHI)?

The CathWorks FFRangio System is FDA cleared and ISO 27001 certified for information security, handling protected health information (PHI), with a Business Associate Agreement (BAA) likely. The Philips Affiniti Series Diagnostic Ultrasound Systems are FDA cleared, HIPAA compliant, and offer a BAA, implementing a defense-in-depth security strategy including firewall, operating system hardening, malware protection, access controls, and patient data encryption.